Danaher Q1 Earnings Beat Estimates, But Revenue Miss, Weak Diagnostics Weigh On Stock

Danaher Q1 earnings beat estimates as bioprocessing drives growth, while diagnostics weakens, and the respiratory outlook is lowered. Importance Rank: 1 read more

Go to News Site